相关实验视频

Updated: May 22, 2025

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

用于基因组和表观基因组编辑的多种Cas9正义体的表征

Gabriel L Butterfield¹, Dahlia Rohm¹, Avery Roberts²

¹Department of Biomedical Engineering, and Center for Advanced Genomic Technologies, Duke University, Durham, NC 27708.

Proceedings of the National Academy of Sciences of the United States of America

|March 12, 2025

概括

研究人员扩展了CRISPR-Cas9工具箱,确定了四种有效用于人类细胞基因编辑的细菌系统. 这些新型系统为各种生物医学应用中基因组和表观基因组的修改提供了新的可能性.

科学领域:

生物技术是生物技术.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

克里斯普尔-Cas9技术改变了生物技术,使得基因组和表观基因组编辑成为可能.
已知的细菌CRISPR-Cas9系统在人体细胞中的有限有效性限制了CRISPR技术的潜力.
扩大CRISPR-Cas9工具箱对于更广泛的应用至关重要.

研究的目的:

描述来自细菌的多种类型II CRISPR-Cas9 系统,以提高人类细胞的功能.
为了识别具有明显的原空间邻基因 (PAM) 和指导RNA特征的新型Cas9变体.
评估这些系统在人类细胞中的基因抑制,激活,核酶和基基编辑活动.

主要方法:

来自各种细菌属和物种的II型CRISPR-Cas9系统的表征.
使用核酶-零dCas9与KRAB域融合用于基因抑制研究.
评估使用dCas9与p300催化域融合的基因激活.
评估人类细胞中的核酶活性和基编辑潜力.

主要成果:

四个新的CRISPR-Cas9系统在人类细胞中展示了强大的和特定的基因抑制.
这些系统在人体细胞中充当高度活跃的核酶.
与常用的Cas9s相比,已识别的系统具有明显的AT丰富的PAM和正交 sgRNA特征.
在S.I.S. uberis Cas9 在抑制,激活,核酶和基编辑方面表现出色.

结论:

这项研究显著扩大了可用于人类细胞的CRISPR-Cas9系统的范围.
已识别的系统提供了正交的PAM识别,扩大了基于CRISPR的基因组和表观基因组编辑的范围.
这些发现使CRISPR技术在生物医学研究和治疗领域的应用更加有效和多样化.

关键词:

克里斯普尔是什么意思?克里斯普尔是什么意思?这就是Cas9的情况.基因组编辑基因组编辑

更多相关视频

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

相关概念视频

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

RNA Editing

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...